Percheron Issues 575 Million Options, Including 10 Million to Director Michael Baker
PER: $0.004 +16.67% · MC: $6M
Percheron Therapeutics issued 575 million options exercisable at one cent by April 2028, covering options linked to earlier rights issues and placements, and has applied for their ASX quotation. Director Michael Baker acquired 10 million of the free-attaching options through his participation in the September placement; the company also issued 50 million options to joint lead managers as fees.

Comments